DK0606210T3 - Hepatocytvækststimulering med hepatocytvækstfaktor og gamma-interferon - Google Patents
Hepatocytvækststimulering med hepatocytvækstfaktor og gamma-interferonInfo
- Publication number
- DK0606210T3 DK0606210T3 DK92912541.7T DK92912541T DK0606210T3 DK 0606210 T3 DK0606210 T3 DK 0606210T3 DK 92912541 T DK92912541 T DK 92912541T DK 0606210 T3 DK0606210 T3 DK 0606210T3
- Authority
- DK
- Denmark
- Prior art keywords
- hepatocyte growth
- stimulation
- growth factor
- gamma
- gamma interferon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/712,284 US5227158A (en) | 1991-06-10 | 1991-06-10 | Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0606210T3 true DK0606210T3 (da) | 1997-05-05 |
Family
ID=24861484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92912541.7T DK0606210T3 (da) | 1991-06-10 | 1992-05-19 | Hepatocytvækststimulering med hepatocytvækstfaktor og gamma-interferon |
Country Status (12)
Country | Link |
---|---|
US (1) | US5227158A (fr) |
EP (1) | EP0606210B1 (fr) |
JP (1) | JPH06508148A (fr) |
AT (1) | ATE151292T1 (fr) |
AU (1) | AU655653B2 (fr) |
CA (1) | CA2109434A1 (fr) |
DE (1) | DE69218956T2 (fr) |
DK (1) | DK0606210T3 (fr) |
ES (1) | ES2101849T3 (fr) |
GR (1) | GR3023613T3 (fr) |
WO (1) | WO1992022321A1 (fr) |
ZA (1) | ZA923980B (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362716A (en) * | 1989-12-27 | 1994-11-08 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines |
ES2257734T3 (es) * | 1992-05-18 | 2006-08-01 | Genentech, Inc. | Activacion de los receptores de oligomerizacion por medio de los ligandos de receptores fusionados. |
US5684136A (en) * | 1992-05-18 | 1997-11-04 | Genentech, Inc. | Chimeric hepatocyte growth factor (HGF) ligand variants |
CA2144081C (fr) * | 1992-09-16 | 2004-11-30 | Filip Roos | Protection contre les lesions du foie au moyen du hgf |
US5464815A (en) * | 1993-09-08 | 1995-11-07 | Genentech, Inc. | Inhibition of heparin-binding |
JP3680114B2 (ja) * | 1993-09-17 | 2005-08-10 | 敏一 中村 | 脳神経障害治療剤 |
US5696086A (en) * | 1994-11-03 | 1997-12-09 | Genentech, Inc. | Methods and kits using macrophage stimulating protein |
US6214344B1 (en) | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
US5686292A (en) | 1995-06-02 | 1997-11-11 | Genentech, Inc. | Hepatocyte growth factor receptor antagonist antibodies and uses thereof |
US5646036A (en) * | 1995-06-02 | 1997-07-08 | Genentech, Inc. | Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies |
US5855918A (en) * | 1995-09-12 | 1999-01-05 | Genentech, Inc. | Cystic fibrosis therapy |
AU7389496A (en) * | 1995-10-05 | 1997-04-28 | Genentech Inc. | Methods and compositions for treating vascular stenosis |
AU7254896A (en) * | 1995-10-05 | 1997-04-28 | Genentech Inc. | Improved angiogenesis using hepatocyte growth factor |
CN1055517C (zh) * | 1996-03-29 | 2000-08-16 | 唐禾天 | 叶片转子式发动机 |
US6280739B1 (en) | 1996-04-18 | 2001-08-28 | Genetics Institute, Inc. | Method of inhibiting angiogenesis using secreted proteins |
IL127558A0 (en) * | 1996-07-03 | 1999-10-28 | Genentech Inc | Hepatocyte growth factor receptor agonists and uses thereof |
US20020136721A1 (en) * | 1998-02-17 | 2002-09-26 | Schwall Ralph H. | Hepatocyte growth factor receptor antagonists and uses thereof |
DE60239522D1 (de) * | 2001-01-09 | 2011-05-05 | Baylor Res Inst Dallas | Verfahren zur behandlung von autoimmunerkrankungen bei einem probanden und diagnostische in-vitro-assays |
US20050123925A1 (en) | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
AU2003251397B2 (en) * | 2002-06-05 | 2009-10-01 | Genentech, Inc. | Compositions and methods for liver growth and liver protection |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
CA2545603A1 (fr) | 2003-11-12 | 2005-05-26 | Biogen Idec Ma Inc. | Variants de polypeptide se liant au recepteur fc neonatal (fcrn), proteines de liaison fc dimeres et techniques associees |
PL1718677T3 (pl) * | 2003-12-19 | 2012-09-28 | Genentech Inc | Jednowartościowe fragmenty przeciwciała stosowane jako środki lecznicze |
US20050244959A1 (en) * | 2004-03-30 | 2005-11-03 | Anne Corlu | Methods for inducing active hepatocytes proliferation, kits using such methods and uses of said kits |
NZ552957A (en) * | 2004-07-20 | 2011-06-30 | Genentech Inc | Compositions and methods of using angiopoietin-like 4 protein |
CN104804095A (zh) * | 2004-08-05 | 2015-07-29 | 健泰科生物技术公司 | 人源化抗c-met 拮抗剂 |
EP1838736B1 (fr) | 2005-01-05 | 2013-03-06 | Biogen Idec MA Inc. | Molécules à liaison cripto |
RU2403261C2 (ru) | 2005-04-15 | 2010-11-10 | Дженентек, Инк. | Варианты бета-цепи hgf |
US8236761B2 (en) * | 2006-07-07 | 2012-08-07 | Washington State University Research Foundation | C-Met receptor regulation by angiotensin IV (AT4) receptor ligands |
EP2043675A2 (fr) * | 2006-07-07 | 2009-04-08 | Washington State University Research Foundation | Régulation du récepteur c-met par des ligands du récepteur de l'angiotensine iv (at4) |
WO2009111707A1 (fr) * | 2008-03-06 | 2009-09-11 | Genentech, Inc. | Polythérapie avec c-met et ses antagonistes |
PL2591006T3 (pl) | 2010-07-09 | 2019-10-31 | Bioverativ Therapeutics Inc | Przetwarzalne cząsteczki jednołańcuchowe i polipeptydy wytworzone przy ich zastosowaniu |
CA2835242A1 (fr) | 2011-06-30 | 2013-01-03 | Genentech, Inc. | Formulations d'anticorps anti-c-met |
WO2013012733A1 (fr) | 2011-07-15 | 2013-01-24 | Biogen Idec Ma Inc. | Régions fc hétérodimères, molécules de liaison les comprenant, et méthodes associées |
SI2802606T1 (en) | 2012-01-10 | 2018-08-31 | Biogen Ma Inc. | Improves the transfer of healing molecules through the hematoencephalic barrier |
TWI828269B (zh) | 2013-03-15 | 2024-01-01 | 美商百歐維拉提夫治療公司 | 因子ix多肽調配物 |
JP2017516458A (ja) | 2014-03-24 | 2017-06-22 | ジェネンテック, インコーポレイテッド | c−met拮抗剤による癌治療及びc−met拮抗剤のHGF発現との相関 |
EP3653712B1 (fr) | 2015-02-04 | 2022-11-30 | F. Hoffmann-La Roche AG | Oligomères antisens tau et leurs utilisations |
CN107636159B (zh) | 2015-02-04 | 2022-06-14 | 百时美施贵宝公司 | 选择治疗性分子的方法 |
RU2720451C1 (ru) * | 2019-05-06 | 2020-04-29 | Анастасия Юрьевна Лаптиёва | Способ стимуляции пострезекционной пролиферации гепатоцитов путем внутрипеченочного введения цианокобаламина |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855238A (en) * | 1983-12-16 | 1989-08-08 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor |
JP2564486B2 (ja) * | 1986-07-14 | 1996-12-18 | 修治 橋本 | 肝細胞増殖因子 |
WO1988009673A1 (fr) * | 1987-06-02 | 1988-12-15 | Schering Corporation | Traitement de l'hepatite b de type chronique avec une combinaison d'interferons alpha et gamma humains recombinants |
US4973478A (en) * | 1987-07-20 | 1990-11-27 | Allelix Biopharmaceuticals, Inc. | Treating inflammation with hepatocyte stimulating factor interferon β2 |
AU2855189A (en) * | 1988-01-25 | 1989-07-27 | Baker Cummins Dermatologicals, Inc. | Method of treating fibrotic disorders |
-
1991
- 1991-06-10 US US07/712,284 patent/US5227158A/en not_active Expired - Lifetime
-
1992
- 1992-05-19 AT AT92912541T patent/ATE151292T1/de active
- 1992-05-19 EP EP92912541A patent/EP0606210B1/fr not_active Expired - Lifetime
- 1992-05-19 AU AU21441/92A patent/AU655653B2/en not_active Expired
- 1992-05-19 DK DK92912541.7T patent/DK0606210T3/da active
- 1992-05-19 WO PCT/US1992/004227 patent/WO1992022321A1/fr active IP Right Grant
- 1992-05-19 DE DE69218956T patent/DE69218956T2/de not_active Expired - Lifetime
- 1992-05-19 JP JP5500867A patent/JPH06508148A/ja active Pending
- 1992-05-19 CA CA002109434A patent/CA2109434A1/fr not_active Abandoned
- 1992-05-19 ES ES92912541T patent/ES2101849T3/es not_active Expired - Lifetime
- 1992-06-01 ZA ZA923980A patent/ZA923980B/xx unknown
-
1997
- 1997-05-30 GR GR970401257T patent/GR3023613T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU655653B2 (en) | 1995-01-05 |
AU2144192A (en) | 1993-01-12 |
ATE151292T1 (de) | 1997-04-15 |
EP0606210A1 (fr) | 1994-07-20 |
WO1992022321A1 (fr) | 1992-12-23 |
US5227158A (en) | 1993-07-13 |
DE69218956D1 (de) | 1997-05-15 |
ZA923980B (en) | 1993-12-01 |
DE69218956T2 (de) | 1997-07-31 |
GR3023613T3 (en) | 1997-08-29 |
EP0606210B1 (fr) | 1997-04-09 |
JPH06508148A (ja) | 1994-09-14 |
ES2101849T3 (es) | 1997-07-16 |
CA2109434A1 (fr) | 1992-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0606210T3 (da) | Hepatocytvækststimulering med hepatocytvækstfaktor og gamma-interferon | |
DE69333321D1 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
DE69433870D1 (de) | Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren | |
DK1316308T3 (da) | Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger | |
EP0253887A1 (fr) | Faible dosage d'interferon pour ameliorer l'efficacite d'un vaccin. | |
DE68905438D1 (de) | Verwendung von interferon-gamma in pharmazeutischen zubereitungen zur behandlung von gefaessstenose. | |
EP0556285A4 (en) | Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents | |
DE68909267T2 (de) | Medikament zur Behandlung von fibrotischer Störung und antifibrotische Verbindung. | |
DK0396903T3 (da) | Anvendelse af IFN-gamma til fremstilling af et farmaceutisk præparat til behandling af ATL | |
DE3685484D1 (fr) | ||
DE3851456D1 (de) | Synergetische immunostimulierende Zusammensetzung und ihre Verwendung. | |
DK162923C (da) | Farmaceutisk praeparat til inhibering af tumorcellevaekst og fremgangsmaade til fremstilling deraf | |
DK155491D0 (da) | Behandling af patienter med kronisk leversygdom | |
DE69332576D1 (de) | Glykolisierte Cytokine | |
DK35588A (da) | Hoejniveau-ekspression i e. coli af oploeseligt, modent humant interleukin-1beta og derivater med aendret biologisk virkning | |
DK222988A (da) | Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer | |
NO960866D0 (no) | Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler | |
ZA928105B (en) | Treatment of anxiety in benzodiazpine-withdrawn patients | |
DK0427633T3 (da) | Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer | |
NO931636D0 (no) | Synergistisk terapi med kombinasjoner av anti-tumor antistoffer og biologisk aktive forbindelser | |
NO911470D0 (no) | Sammensetning og behandling med biologisk aktive peptiderog visse anioner. | |
DK0381584T3 (da) | Anvendelse af visse gamma-interferoner til behandling af ovariecancer | |
DK1311286T3 (da) | Behandling af hepatitis C med thymosin og pegyleret interferon |